Critically Ill Intensive Care Unit Patients
11
6
7
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
18%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis
Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes
Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit
SOFA-2 Score in Turkish ICUs
Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients
Ketamine Sedation in the ICU (KANINE) RCT
Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients
Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients
Phosphate Urine Excretion in Critically Ill Patients
Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study
The Four Supports Study: Family Support Intervention in Intensive Care Units